Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128917) titled 'A Prospective, Multicenter, Observational Study on the Safety and Efficacy of Cetuximab N01 Injection in the Real-World Treatment of Colorectal Cancer' on July 28.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Yantai Yuhuangding Hospital
Condition:
Wild-type RAS colorectal cancer
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-08-01
Target Sample Size: Cetuximab treatment group:5000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=324749
Published by HT Digital Content Services with permission fr...